Cardiac Rhythm Management Devices Batteries Market
                     Cardiac Rhythm Management Devices Batteries Market- Size, Share, Outlook,
and Opportunity Analysis, 2020- 2027
Implantable  biomedical  devices  batteries  are  used  in  cardiac  rhythm
management  (CRM)  devices.  CRM  devices  are  used  in  the  treatment  of
cardiovascular  diseases  (CVDs).  Some  of  the  implantable  cardiac  devices
include,  implantable  cardiac  pacemakers  (ICP),  implantable  cardioverter
defibrillators  (ICD),  and  cardiac  resynchronization  therapy  devices  (CRT)
The global cardiac rhythm management devices batteries market is estimated to
account for US$ 446.1 Mn in 2019 and is expected to reach US$ 581.0 Mn by
2027.
Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-
sample/3173 
Increasing adoption and advancement in lithium anode batteries is expected to 
boost growth of the global cardiac rhythm management devices batteries market 
over the forecast period. This is attributed to various advantages of lithium anode
batteries such as light weight, high reliability and predictability, high energy 
density, small size, and long service life. Major institutes are focused on R&D in 
lithium anode batteries. For instance, in July 2018, a study, ‘Ionic Liquid-Based 
Electrolyte Membranes for Medium-High Temperature Lithium Polymer Batteries’ 
published in the journal MDPI Membranes, reported development of PEO-LiTFSI 
Li+-conducting membranes, containing the PYR14TFSI ionic liquid, as electrolyte
separators for all-solid-state lithium polymer batteries operating at medium-high 
temperatures.
Moreover, improvements in CRM devices is also expected to propel growth of the
market over the forecast period. For instance, in October 2019, a study, 
‘Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for 
cardiac implantable electronic devices’ published in the journal Biomaterials, 
reported development of a special protective membrane made of cellulose that 
decreases the build-up of fibrotic tissue around cardiac pacemaker implants.
North America region held dominant position in the global cardiac rhythm 
management devices batteries market in 2018, accounting for 37.7% share in 
terms of value, followed by Europe region.Increasing product recall associated 
with CRM devices is expected to hinder growth of the global cardiac rhythm 
management devices batteries market. For instance, in February 2019, 
Medtronic, Inc. recalled 13,440 dual chamber implantable pulse generators in the
U.SLi-Ion batteries are prone to explosion and thus require protection from being 
overcharged and discharged too far. Such drawbacks are also expected to 
hamper growth of the market over the forecast period.
Key players in the market can focus on R&D in sodium-ion batteries. Although 
lithium-ion batteries are considered a major source of energy storage, depleting 
resources for lithium and high cost associated with mining and refining, may pave
a way for other alternatives. Sodium-ion batteries are cheaper and offer effective 
operation. Therefore, increasing adoption of sodium-ion batteries in CRM devices
is expected to offer lucrative growth opportunities to market players.Moreover, 
increasing prevalence of CVDs and other heart-related diseases due to ganging 
life
Moreover, cathode materials may lead to increased risk of developing serious 
complications, which has prompted manufacturers to focus on the use of less 
toxic battery chemistry. The demand for silver vanadium oxide as cathode 
material is increasing for use in CRM devices. Such scenarios are expected to 
aid in growth of the global cardiac rhythm management devices batteries market 
over the forecast period.
Major players operating in the global cardiac rhythm management devices 
batteries market include, Medtronic, Inc., Boston Scientific Corporation, St. Jude 
Medical, Inc., Greatbatch, Inc. (Integer), EaglePicher Technologies, LLC, 
Quallion LLC, and BIOTRONIK SE & Co. KG.  
Increasing product recall and warnings are expected to hinder growth of the 
market. For instance, in May 2019, The U.S. Food and Drug Administration 
(FDA) raised alarm about premature battery depletion in Azure, Astra, Percepta, 
Serena, and Solara pacemaker models of Medtronic, Inc.In November 2018, the 
U.S. FDA warned Zeller Power Products, a replacement battery producer for 
Cardiac Science's PowerHeart Automated External Defibrillator (AED) G3 over 
unavailability of design validation documentation to justify the battery's five-year 
shelf life.
Get the main link:-  https://www.coherentmarketinsights.com/market-insight/cardiac-rhythm-
management-devices-batteries-market-3173 
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/